Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Baicalin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Myricetin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021
Boesenbergia rotunda extract
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/17/2020
Narciclasine
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/02/2020
Panduratin A
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/17/2020
EGYVIR
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/18/2020
Oleanolic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/02/2020
Andrographolide
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/25/2020
Camellia sinensis extract
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
Terminalia chebula extract
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
Herbacetin
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
Pectolinarin
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
FRIL
Potential treatment - pre-clinical evidence Natural product Antiviral Jul/24/2020
Scutellaria baicalensis extract
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021
Actidione
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
Procyanidin
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/01/2021
Epigallocatechin Gallate
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021
Elaidic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Jun/16/2020
Nanchangamycin
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
Chenodeoxycholic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020